New study aims to boost IUI success with a simple, fixed hormone dose

NCT ID NCT07153367

Recruiting now Disease control Sponsor: Centre Hospitalier Intercommunal Creteil Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 2 trial is testing whether a fixed dose of the hormone follitropin delta (Rekovelle) can improve ovarian stimulation for intrauterine insemination (IUI) in women with regular cycles. The goal is to promote the growth of two mature eggs per cycle to increase pregnancy chances while minimizing the risk of multiple pregnancies. Eighty participants aged 18-38 will receive the same dose and be monitored closely.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: follitropin delta (Rekovelle)
What this could lead to: If successful, this could offer a simpler, more effective starting dose for ovarian stimulation in intrauterine insemination, potentially increasing pregnancy rates while lowering the risk of multiple births.
What could go wrong: This is a small Phase 2 trial with only 80 participants, so results may not apply to all patients. The fixed dose may not work for everyone, and there is still a risk of ovarian hyperstimulation or multiple pregnancy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFERTILITY INSEMINATION

Contacts and locations

Locations

Cabinet Dr Elodie Descat-Polyclinique Jean Villar
RECRUITING

Bruges, 33520, France
Cabinet Dr Géraldine PORCU-Institut de Médecine de la Reproduction
RECRUITING

Marseille, 13008, France
Cabinet Dr Nathalie Massin- Hôpital Américain De Paris
SUSPENDED

Neuilly-sur-Seine, 92200, France
Cabinet Dr Nicolas Chevalier-Centre AMP Saint Roch
RECRUITING

Montpellier, 34070, France
Chi Creteil
RECRUITING

Créteil, 94000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.